Epidemiology and health economic of colorectal cancer in Germany;Epidemiologie und gesundheitsökonomische bedeutung des darmkrebses in Deutschland

Internist

Volumn 44, Issue 3, 2003, Pages 268-277

  Knopnadel J ^a   Altenhofen, L ^a   Brenner, G ^a  

^a Bundesrepublik Deutschland   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; CANCER MORTALITY; CANCER RISK; COLORECTAL CANCER; GERMANY; HEALTH ECONOMICS; HUMAN; INTESTINE CANCER; RECTUM CARCINOMA; REVIEW;

EID: 0037354345     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-002-0793-4     Document Type: Review

References (43)

1. Robert Koch-Institut (1999) Gesundheitsberichterstattung für Deutschland. Schwerpunktbericht: "Entwicklung und Überlebensraten von Krebspatienten in Deutschland". http://www.rki.de/GBE/KREBS/KREBS.HTM
2. Becker N, Wahrendorf J (Hrsg) (1998) Krebsatlas der Bundesrepublik Deutschland 1981-1990, Springer, Berlin Heidelberg New York http://www.dkfz-heidelberg.de/epi/Home_d/Programm/AG/Praevent/ Krebshom/main/deutsch/frame.htm
3. Berrino F, Capocaccia R, Estève J et al. (eds) (1999) Survival of cancer patients in Europe: the EUROCARE-2 Study. IARC Scientific Publication No. 151
4. Micheli A, Mugno E, Krogh V et al. and the EUROPREVAL Working Group (2002) Cancer prevalence in European registry areas. Ann Oncol 13: 840-865
5. Ferlay J, Bray F, Pisani P, Parkin DM (2001) GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide. IARC Press, Lyon, http://www-dep.iarc.fr/ globocan/globocan.html
6. Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland (2002) Krebs in Deutschland; 3.erweiterte, aktualisierte Ausgabe. Saarbrücken, http://www.rki.de/KREBS
7. Block G, Patterson B, Subar A (1992) Fruit, vegetables, and cancer prevention: A review of the epidemiological evidence. Nutr Cancer 18: 1-29
8. Willett WC, Stampfer MJ, Colditz GA, Rosner BA Speizer FE (1990) Relation of meat,fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 323: 1664-1672
9. Willett WC (1995) Diet, nutrition, and avoidable cancer. Environ Health Perspect 103 (Suppl): 165-170
10. Franceschi S, La Vecchia C (1994) Alcohol and the risk of cancers of the stomach and colon-rectum. Dig Dis 12: 276-289
11. Schmiegel W, Adler G, Frühmorgen P et al. (2000) Kolorektales Karzinom: Prävention und Früherkennung in der asymptomatischen Bevölkerung - Vorsorge bei Risikopatienten - Endoskopische Diagnostik, Therapie und Nachsorge von Polypen und Karzinomen. Deutsche Gesellschaft für Verdauungs- und Stoffwechselkrankheiten/Arbeitsgemeinschaft für Gastroenterologische Onkologie: Ergebnisse einer interdisziplinären Konsensuskonferenz, Bochum 1999. Z Gastroenterol 38: 49-75
12. Jänne PA, Mayer RJ (2000) Primary care: Chemoprevention of colorectal cancer. N Engl J Med 342: 1960-1968
13. Byers T (2000) Diet, colorectal adenomas, and colorectal cancer. N Engl J Med 342: 1206-1207
14. Suleiman S, Rex DK, Sonnenberg A (2002) Chemoprevention of colorectal cancer by aspirin: A cost-effectiveness analysis. Gastroenterology 122: 78-84
15. Pignone MP, Rich M, Teutsch SM, Berg AO, Lohr KN, (2002) Screening for colorectal cancer in adults: Systematic evidence review no. 7. AHRQ publication: 02-S003
16. Bond JH for the Practice Parameters Committee of the American College of Gastroenterology (2000) Polyp guideline: Diagnosis, treatment, and surveillance for patients with colorectal polyps. Am J Gastroenterol 95: 3053-3063
17. Mandel JS, Bond JH, Church TR et al. (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 328: 1365-71
18. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O (1996) Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348: 1467-1471
19. Hardcastle JD, Chamberlain JO, Robinson MHE et al, (1996) Randomised controlled tríal of faecal-occult-blood screening for colorectal cancer. Lancet 348: 1472-1477
20. Ransohoff DF, Sandler RS (2002)Screening for colorectal cancer. N Engl J Med 346: 40-44
21. Moss SM, Hardcastle JD, Coleman DA, Robinson MHE, Rodrigues VC (1999) Interval cancers in a randomised controlled trial of screening for colorectal cancer using a faecal occult blood test. Int J Epidemiol 28: 386-390
22. Winawer SJ, Zauber AG, Gerdes H et al. for The National Polyp Study Workgroup (1996) Risk of colorectal cancer in the families of patients with adenomatous polyps. N Engl J Med 334: 82-87
23. Towler B, Irwig L, Glasziou P, Kewenter J, Weller Q, Silagy C (1998) A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ 317: S59-S65
24. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS (2000) The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343: 1603-1607
25. Lieberman DA, Weiss DG, for the Veterans Affairs Cooperative Study Group 380 (2001) One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 345: 555-560
26. Woolf SH (2000) The best screening test for colorectal cancer - a personal choice. N Engl J Med 343: 1641-1643
27. Winawer SJ, Zauber AG, Ho MN et al. (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329: 1977-1981
28. Selby JV, Friedman GD, Quesenberry CP, Weiss NS (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326: 653-657
29. Muller AD, Sonnenberg A (1995) Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans. Ann Intern Med 123: 904-910
30. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM (1992) Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84: 1572-1575
31. Brenner H, Arndt V, Stürmer T, Stegmaier C, Ziegler H, Dhom G (2002) Präventionspotenzial endoskopischer Vorsorgeuntersuchungen für kolorektale Karzinome. Dtsch Ärztebl 33: A2186-A2192
32. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF (2000) Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 343: 169-74
33. Lieberman DA, Weiss DG, Bond JH (2000) Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 343: 162-168
34. Deutsches Ärzteblatt 38: A2508-A2511
35. Schulenburg JM, Uber A (1995) The costs of cancer to society. In: Champey Y (ed) The challenges in studying the socioeconomic dimensions in cancer therapy. Yardley
36. Altenhofen L, Brenner G, Flatten G, Hofstädter F, Kutz R, Oliveira J (1999) Modellprojekt Früherkennung des kolorektalen Karzioms. Wissenschaftliche Reihe Bd. 55, Köln
37. Frazier LA, Colditz GA, Fuchs CS, Kuntz KM (2000) Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 284: 1954-1961
38. Wagner J, Tunis S, Brown M, Ching A, Almeida R (1996) Cost-effectiveness of colorectal cancer screening in average-risk adults. In: Young GP, Rozen P, Levin B (eds) Prevention and early detection of colorectal cancer. Saunders, England, pp 321-3S6
39. Sonnenberg A, Delco F (2002) Cost-effectiveness of a single colonoscopy in screening for colorectal cancer. Arch Intern Med 162: 163-8
40. Vijan S, Hwang EW, Hofer TP, Hayward RA (2001) Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med 111: S93-601
41. Schmiegel W, Riemann J (2000) Beurteilung von Screeningverfahren zur Früherkennung und Prävention kolorektaler Karzinome, Gutachten für den Arbeitsausschulß Prävention des Bundesausschusses Ärzte und Krankenkassen Bochum/Ludwigshafen
42. Winawer SJ, Hetscher RH, Miller L et al. (1997) Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 112: 594-642
43. US Preventive Services Task Force (1997) Guide to clinical preventive services, 2nd ed. Washington, pp 89-103